Τόμος 19 (2005) – Τεύχος 1 – Άρθρο 1 – Επιθεώρηση Κλινικής Φαρμακολογίας και Φαρμακοκινητικής-Διεθνής Έκδοση – Volume 19 (2005) – Issue 1 – Article 1 – Epitheorese Klinikes Farmakologias και Farmakokinetikes-International Edition

1.      Department of Health Visiting, Faculty of Health and Caring Professions, Technological Educational Institution of Athens, Athens, Greece

2.     Peripheral Infirmary Terpyllou, General Hospital of Kilkis, Kilkis, Greece

3.     Peripheral Infirmary Vathis, General Hospital of Kilkis, Kilkis, Greece

4.     School of Business Administration and Economics, Technological Educational Institution of Athens, Athens, Greece

5.     General Department of Essential Medical Subjects, Faculty of Health and Caring Professions, Technological Educational Institution of Athens, Athens, Greece

 Accepted for publication: 9 January 2005

pharmakonpress[at]pharmakonpress[.]gr

2.       Desmond R.A., Soong S.: Epidemiology of malignant melanoma. Surg. Clin. North Amer. 83: 1-29 (2003)

3.       Geller A.C., Annas G.D.: Epidemiology of melanoma and nonmelanoma skin cancer. Seminar-Oncology-Nursing. Pp. 2-11, 2003

4.       Lee J.E.: Factors associated with melanoma incidence and prognosis. Semin. Surg. Oncol. 12: 379-385 (1996)

5.       Wang C.Y., Brodland D.G., Su W.P.: Skin cancers associated with acquired immunodeficiency syndrome. Mayo Clin. Proc. 70: 766-72 (1995)

6.       Rhodes A.R., Weinstock M.A., Fitzpatrick T.B., et al.: Risk factors for cutaneous melanoma. A practical method of recognizing predisposed individuals. JAMA 258: 3146- 3154 (1987)

7.       Albert L.S., Rhodes A.R., Sober A.J.: Dysplastic melanocytic nevi and cutaneous melanoma: markers of increased melanoma risk for affected persons and blood relatives. J. Am. Acad. Dermatol. 22: 69-75 (1990)

8.       Armstrong B.K.: Epidemiology of malignant melanoma: intermittent or total accumulated exposure to the sun? J. Dermatol. Surg. Oncol. 14: 835-849 (1988)

9.       Marks R.: An overview of skin cancers. Incidence and causation. Cancer 75: 607-612 (1995)

10.     Rodenas J. et al.: Sun exposure, pigmentary traits and risk of cutaneous malignant melanoma. Cancer-causes-control 7: 275-283 (1996)

11.      Staurianeas N.G., Agelakopoulos Ch.: Malignant melanoma. Modern Dermatological Oncology. Medical publications, P.Ch. Paschalidis, Pp. 129-156, Αθήνα, 2001

12.     Bito T., Oka M.: UV-induced skin damage. Toxicology 189(1-2): 21-39 (2003)

13.     Stratigos A.I: The molecular basis of skin photocarcinogenesis, Iatriki 77: 432-446 (2000)

14.     Kapetanakis l.: Illustrated dermatology. Scientific publications Parisianos, Pp. 217-220, Αθήνα, 1987

15.     Zoumpourlis B., Solakidi S., Papathoma A., Papaevangeliou D.: Alterations in signal transduction pathways implicated in tumor progression during multistage mouse skin carcinogenesis. Carcinogenesis 24: 1159-1162 (2003)

16.     Keller, Schmidt, Peipkorn: Expression of the tumor suppressor gene product p16INK4 in benign and malignant Melanocytic lesions. J. Invest. Dermatol. 110: 932- 938 (1998)

17.     Polyzos A., Papadopoulos O.: Development in surgical classification and preventive melanoma treatment, Iatriki 73: 420-424(1998)

18.     Krag S., Harlow S., Weaver D., Ashikaga T.: Techniques of sentinel node resection in melanoma and breast cancer: probe-guided surgery and lymphatic mapping. Eur. J. Surg. Oncol. 24: 89-93(1998)

18.     Spanos P.: General Surgery. Volume 1, pp. 260-265, University Studio Press, Thessaloniki, 2001

19.     Brown C.K., Kirkwood J.M.: Medical management of melanoma. Surg. CHn. North Amer. 82. 283-322 (2003)

20.    Geraghty P., Johnson T, Sondak V., Chang A.: Surgical therapy of primary cutaneous Melanoma. Semin. Surg. Oncol. 12 386-393 (1996)

21.     Johnson T.M, Smith J.W., Nelson B.R, Chang A.: Current therapy for cutaneous melanoma. J. Am. Acad. Dermatol. 32: 689-707 (1995)

22.     Veronesi U., Cascinelli N.: Narrow excision (1-cm margin). A safe procedure for thin cutaneous melanoma. Arch. Surg. 126: 4384-4341 (1991)

23.     Kian A.K., Geara F.B., Byers R.M., Peters L.J.: Radiotherapy for Melanoma. Cutaneous Melanoma, Quality Medical Publishing, pp: 384-403, St Louis, 1998

24.     Gennatas K.S.: Melanoma immunotherapy. Modern dermatological oncology. Medical Publications, P.Ch. Paschalidis, pp. 161-163, Αθήνα, 2001

25.     Kirkwood J.M., Strawderman W.H., Ernstoff M.S., et al.: Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma. J. Clin. Oncol. 14: 7-17 (1996)

26.     Rosenberg S.A, Yang J.C, Topalian S.L., et al.: Treatment of 283 consecutive patients with metastatic melanoma or renal cell cancer using high-dose bolus interleukin 2. JAMA 271: 907-913 (1994)

27.     Zettersten E., Shaikh L., Ramirez R., Sabet M.: Prognostic factors in primary cutaneous melanoma. Surg. Clin. North Amer. 83: 61-75 (2003)

28.    Schaffer J., Rigel D., Kopf A., Bologna J.: Cutaneous melanoma – Past, present, and future. J. Am, Acad. Dermatol. 51: S65-S69 (2004)

pharmakonpress[at]pharmakonpress[.]gr

pharmakonpress[at]pharmakonpress[.]gr